Gilder Gagnon Howe & CO LLC C4 Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $134,737 - $704,576	-26,628 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $532,293 - $884,848	26,628 New	26,628 $646,000
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $1.16 Million - $1.85 Million	-39,506 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $1.42 Million - $2 Million	39,506 New	39,506 $1.77 Million

129

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $180M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.